Article
Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.
In vivo (Athens, Greece) - 1 Jan 2000
DE Pinho Pessoa Flávia Melo Cunha, Nogueira Beatriz Maria Dias, Machado Caio Bezerra, Barreto Igor Valentim, DA Costa Machado Anna Karolyna, Gadelha Renan Brito, DE Sousa Oliveira Deivide, Ribeiro Rodrigo Monteiro, Silva Fabiana Aguiar Carneiro, Gurgel Lívia Andrade, Medeiros Jaira Costa, DA Rocha Maciel Aurélia, Lopes Germison Silva, Vieira Ricardo Parente Garcia, DE Moraes Filho Manoel Odorico, DE Moraes Maria Elisabete Amaral, Khayat André Salim, Moreira-Nunes Caroline Aquino
Abstract excerpt
BACKGROUND/AIM: Acute myeloid leukemia (AML) is a myeloproliferative neoplasm marked by abnormal clonal expansion of hematopoietic progenitor cells, displaying karyotypic aberrations and genetic mutations as prognostic indicators. The World Health Organization (WHO) and the European LeukemiaNet guidelines categorize BCR::ABL1 p190+ AML as high risk. This study explored the identification of the increased...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.